Therapeutic Asset Ratings
4,361 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ibrutinib
Burkitt Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Ibrutinib
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
MITOMYCIN C
Appendix Cancer
National Cancer Institute (NCI)
P2
B
(63)
MITOMYCIN C
Peritoneal Mesothelioma
National Cancer Institute (NCI)
P2
B
(63)
Nivolumab
Rectum Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(63)
Pomalidomide
Myelodysplastic Syndrome
National Cancer Institute (NCI)
P2
B
(63)
PREDNISONE TABLETS
Secondary Acute Myeloid Leukemia
National Cancer Institute (NCI)
P2
B
(63)
Rapamycin
Disease Related To Hematopoietic Stem Cell Transplant
National Cancer Institute (NCI)
P2
B
(63)
Veliparib
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P2
B
(63)
(+)-VINCRISTINE
Myelodysplastic Syndrome With Ring Sideroblasts
National Cancer Institute (NCI)
P2
B
(63)
(+)-VINCRISTINE
Refractory Anemia
National Cancer Institute (NCI)
P2
B
(63)
Vinorelbine
Recurrent Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2
B
(63)
Ziv-Aflibercept
Ovarian Cancer
National Cancer Institute (NCI)
P2
B
(63)
Ziv-Aflibercept
Cutaneous Melanoma
National Cancer Institute (NCI)
P2
B
(63)
Cediranib
Adult Solid Neoplasm
National Cancer Institute (NCI)
P1/2
B
(63)
Cpx-351
Myelodysplastic Syndrome
National Cancer Institute (NCI)
P2/3
B
(63)
Decitabine
Myelodysplastic Syndrome/Acute Myeloid Leukemia
National Cancer Institute (NCI)
P2/3
B
(63)
Irinotecan
Adult Mixed Glioma
National Cancer Institute (NCI)
P1/2
B
(63)
Vinorelbine
Cancer Of Unknown Primary Site
National Cancer Institute (NCI)
P1/2
B
(63)
Dabrafenib
Anaplastic Astrocytoma
National Cancer Institute (NCI)
P4
B
(62)
Dabrafenib
Malignant Glioma
National Cancer Institute (NCI)
P4
B
(62)
Azacitidine
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)
P3
B
(62)
Binimetinib
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(62)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P3
B
(62)
Showing 526 to 550 of 4,361 assets
Previous
Page 22 of 175
Next